Imatinib Mesylate — The New Gold Standard for Treatment of Chronic Myeloid Leukemia
K. Peggs
and
S. Mackinnon
- 13 Mar, 2003
This article requires a subscription.
Login via Athens or your institution
Already a print subscriber? Activate your online access
Not a Subscriber?
